Home/Companies/Biotech/Biophta

Biophta

Biotech·

France·Active·2yr hold

Entry

2024

Hold

2yr

Status

Active

Who owns Biophta?

Biophta is a French Biotech company, currently owned by Go Capital since 2024 and 2 other investors.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY

Most recent investor

Lazard Elaia Capital

Elaia Digital Venture Fund V · 2024 · VC

3 ownership periods · full history below

Key facts

HQFrance

SectorBiotech

Websitewww.biophta.com

Ownership history

3 ownership periods · co-invest detected

Active

Co-held by Go Capital, Lazard Elaia Capital and Elaia Partners since 2024.

Co-invest · 3 holders · 2024 · present

Go CapitalActive

2024 · present(2yr) · GOCA3 · 2023 · VC

Elaia PartnersActive

2024 · present(2yr) · DTS3 · 2024 · VC

Lazard Elaia CapitalActive

2024 · present(2yr) · Elaia Digital Venture Fund V · 2024 · VC

More from Elaia Digital Venture Fund V

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare

Active

The Carlyle GroupChina

Adagene

Active

General AtlanticChina

Advanced Cell Diagnostics

Questions

Who owns Biophta?

Biophta is currently owned by Go Capital, Lazard Elaia Capital and 1 other, through Elaia Digital Venture Fund V, since 2024.

When did Go Capital and 2 others acquire Biophta?

Go Capital and 2 others acquired Biophta in 2024.

Who has owned Biophta over time?

Biophta has been through 3 private-equity ownership periods: Go Capital · via GOCA3 · since 2024; Lazard Elaia Capital · via Elaia Digital Venture Fund V · since 2024; Elaia Partners · via DTS3 · since 2024.

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue